申请人:Aragon Pharmaceuticals, Inc.
公开号:US08299112B2
公开(公告)日:2012-10-30
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
本文描述了一些雌激素受体调节剂化合物。还描述了包括上述化合物的药物组合物和药物,以及使用这些雌激素受体调节剂,单独或与其他化合物结合使用,治疗依赖于雌激素受体的疾病或病状的方法。